Fig. 1 · Structure

Documents & Downloads

Pim1/AAK1-IN-1

Cat. No. A11476 CAS 1093222-27-5

LKB1/AAK1 dual inhibitor

Pim1/AKK1-IN-1 is a potent multi-kinase inhibitor with Kd values of 35 nM/53 nM/75 nM/380 nM for Pim1/AKK1/MST2/LKB1 respectively, and also inhibits MPSK1 and TNIK.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Cellular Effect

Cell Line Activity Value Description Reference
Huh-7 CC50 > 10 μM Cytotoxicity against human HuH7 cells infected with Ebolavirus Kikwit isolate after 48 hrs by Celltiter-glo reagent based luminescence assay [PMID: 31136173]
Huh-7 CC50 > 50 μM Cytotoxicity against human HuH7 cells infected with DENV2 New Guinea C by microplate alamar blue assay [PMID: 31136173]

Pim1/AAK1-IN-1 Research Summary

This section summarizes 2 in vitro studies of Pim1/AAK1-IN-1 from 1 published reference. In vitro models include L6 myoblasts.

Pim1/AAK1-IN-1 In Vitro Studies

In L6 myoblasts, studies compared culture with or without 1 μM Pim1/AAK1-IN-1 for 24 h with 10% static mechanical loading. Under these conditions, Pim1/AAK1-IN-1 pretreatment abolished AMPK phosphorylation, while compound treatment rescued p70S6K phosphorylation in loaded muscle cells. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

AMPK phosphorylation under static mechanical loading

Cell-based study · L6 myoblasts [1]

L6 myoblasts were cultured with or without 1 μM Pim1/AAK1-IN-1 for 24 h with 10% static mechanical loading. In this comparison, compound pretreatment abolished AMPK phosphorylation.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
AMPK phosphorylationReported result Pim1/AKK1-IN-1 pretreatment abolished AMPK phosphorylation[1]

Literature-Reported Treatment Conditions

Treatment concentration
1 μM
Exposure duration
for 24 h with 10% SL
Method
cells were cultured with/without 1 μM Pim1/AKK1-IN-1
Co-treatment
Other interventions in this design: static mechanical loading (SL) 10%. Compound effect isolated by the comparison: with/without 1 μM Pim1/AKK1-IN-1 for 24 h with 10% SL.
Reported limits
Not stated in the sentences used: vehicle.
Methods and source locations

Compound reported in the paper: Pim1/AAK1-IN-1; Compound label in the paper: Pim1 AKK1-IN-1

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Materials and Methods > Cell Culture (S1); Materials and Methods > Mechanical Loading and Drug Treatments (S12, S18); Figure 3 legend (S189)

AMPK phosphorylation: AMPK phosphorylation; comparator: with/without 1 μM Pim1/AKK1-IN-1 for 24 h with 10% SL — Figure 3 legend (S189)

p70S6K phosphorylation in loaded myoblasts

Cell-based study · L6 myoblasts [1]

L6 myoblasts were cultured with or without 1 μM Pim1/AAK1-IN-1 for 24 h with 10% static mechanical loading. In this comparison, compound treatment rescued p70S6K phosphorylation in loaded muscle cells.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
p70S6K phosphorylationReported result rescued p70S6K phosphorylation in loaded muscle cells[1]

Literature-Reported Treatment Conditions

Treatment concentration
1 μM
Exposure duration
for 24 h with 10% SL
Method
cells were cultured with/without 1 μM Pim1/AKK1-IN-1
Co-treatment
Other interventions in this design: static mechanical loading (SL) 10%. Compound effect isolated by the comparison: with/without 1 μM Pim1/AKK1-IN-1 for 24 h with 10% SL.
Reported limits
Not stated in the sentences used: vehicle.
Methods and source locations

Compound reported in the paper: Pim1/AAK1-IN-1; Compound label in the paper: Pim1 AKK1-IN-1

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Materials and Methods > Cell Culture (S1); Materials and Methods > Mechanical Loading and Drug Treatments (S12, S18); Figure 3 legend (S189)

p70S6K phosphorylation: p70S6K phosphorylation; comparator: with/without 1 μM Pim1/AKK1-IN-1 for 24 h with 10% SL — Figure 3 legend (S189)

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 1093222-27-5
Applications

LKB1/AAK1 dual inhibitor

Formula C20H13N5O
Molecular Weight 339.35
Synonyms LKB1/AAK1 dual inhibitor
SMILES
N#CC1=CC=C(C2=CN=C3C(C(NC(C4=CC=CN=C4)=O)=CN3)=C2)C=C1

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Pim1/AAK1-IN-1 Research References

  1. [1] Zhou X, Zhu S, Li J, et al. Mechanical Loading Modulates AMPK and mTOR Signaling in Muscle Cells. J Proteome Res (2024). PMID: 39213513 DOI: 10.1021/acs.jproteome.4c00242 Source material

Added to your cart

View Cart Checkout
Loading...